hg_42955.1

Basic information about the TSS

---

TSS ID: hg_42955.1 Species: human Chr: chr3		Start: 69052262 End: 69052306 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000488010.5 AB209109 AK312697 BC033771 BC008454 Distance: 0 GeneID: 7110 HGNC/MGI_ID: HGNC:11870 UniProt_ID: F8WF45 Q6PII6

Gene_name: TATA element modulatory factor 1 Gene_symbol: TMF1 Gene_synonyms: ARA160 TMF Gene_source: HGNC:11870

TATA-Box annotation

---

Distance to TSS:	49
Nearest PromoterID:	NM_007114
Entrez ID:	7110
Nearest Unigene:	Hs.267632
Nearest Refseq:	NM_007114
Nearest Ensembl:	ENSG00000144747
Gene Name:	TATA element modulatory factor 1
Gene Alias:	ARA160|TMF
Gene Description:	TATA element modulatory factor 1
Gene Type:	protein-coding
CpG%:	0.095
GC%:	0.606965
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMF1 p2@TMF1 p3@TMF1 p4@TMF1 p5@TMF1 p6@TMF1
Sample		p1@TMF1	p2@TMF1	p3@TMF1	p4@TMF1	p5@TMF1	p6@TMF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	11.30	5.26	1.56	0.78	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.14	2.63	3.64	0.20	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.54	4.44	3.67	0.19	0.77	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.98	5.20	2.70	0.00	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.47	4.27	2.25	0.00	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.33	5.04	2.52	0.58	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.98	7.41	2.61	0.22	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.05	6.30	3.63	0.48	0.00	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.89	4.27	2.56	1.50	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	6.38	9.85	1.74	0.58	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	17.79	8.49	9.30	0.81	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.80	9.35	8.54	0.81	0.41	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	18.21	3.87	2.10	0.48	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.38	2.26	0.75	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.44	0.88	3.29	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.10	2.01	1.76	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.51	1.53	1.75	0.44	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.97	2.95	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	20.26	3.73	1.07	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	14.59	2.26	1.35	0.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.84	2.81	1.74	0.53	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.53	1.90	1.73	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.89	2.33	1.68	1.03	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.05	2.67	0.97	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.16	2.06	1.03	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.66	2.53	2.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	3.30	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.32	2.83	3.06	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.11	2.26	0.97	0.16	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.67	2.35	0.90	0.18	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.63	2.51	1.67	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.94	1.95	1.56	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.18	1.48	4.01	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.36	2.14	0.82	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.91	2.06	1.87	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.65	1.92	1.34	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.47	1.23	3.27	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.49	2.82	3.22	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.13	2.16	2.70	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.32	1.92	2.16	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.41	2.12	1.41	0.24	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.98	3.22	2.05	0.29	0.15	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.45	3.59	2.11	0.21	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.08	2.10	1.92	0.52	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.88	3.61	2.21	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.89	2.79	2.09	0.47	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.19	2.16	1.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.69	2.38	1.49	0.30	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.67	1.44	3.83	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.00	4.25	1.82	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.60	3.07	1.23	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.46	3.11	3.34	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	27.98	13.99	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.10	2.48	2.48	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.89	2.98	2.65	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	4.19	6.71	0.84	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	2.76	0.92	0.46	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.96	1.62	3.24	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.80	2.57	2.57	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.46	3.77	3.46	0.00	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	1.41	2.82	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	3.36	2.24	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	18.31	1.59	1.59	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.65	3.74	3.06	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.52	3.90	2.60	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.46	0.71	4.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	15.79	15.79	0.00	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	1.95	4.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.88	0.99	2.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	3.28	1.88	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.53	2.32	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.01	1.86	3.40	0.93	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.29	1.83	2.14	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	15.84	7.44	2.38	0.63	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	10.91	4.17	2.09	0.48	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	21.12	7.89	2.80	0.64	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	17.19	1.49	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	9.71	1.67	2.01	0.33	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	10.85	2.55	2.55	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	3.30	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.94	2.71	4.52	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	6.78	2.43	0.87	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	25.03	7.04	5.48	0.78	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	22.13	4.89	2.06	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.28	6.41	2.79	1.39	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	29.98	2.94	4.70	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.28	3.30	3.38	0.32	0.16	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	14.20	3.23	1.94	0.65	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	3.20	4.27	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	14.47	5.01	1.67	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	8.32	1.66	1.25	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	9.29	3.77	1.26	0.25	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	10.47	0.98	1.96	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	6.70	2.13	1.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	4.42	0.44	0.66	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.12	1.26	1.08	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.52	0.82	0.00	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	14.53	5.49	3.20	0.69	0.23	0.23
Anulus Pulposus Cell, donor2	11463-119B5	16.90	4.16	1.96	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.88	2.70	2.70	0.45	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.99	3.91	2.17	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	6.42	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.47	2.99	2.99	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	1.26	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	0.66	0.00	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	2.92	1.30	0.32	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.62	5.83	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.94	2.97	1.78	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.07	3.39	2.64	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	4.35	2.18	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.85	2.80	1.32	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	5.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.54	3.17	1.66	0.45	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	3.75	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.45	4.16	0.76	0.94	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.49	4.81	1.34	0.00	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	0.98	3.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.29	3.15	1.49	0.50	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	10.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.95	3.09	1.03	0.34	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	4.19	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	4.37	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	1.52	1.52	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	2.42	0.00	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	1.71	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.05	4.06	1.07	0.21	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.00	5.16	0.52	0.26	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.32	1.88	2.82	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.29	4.18	1.93	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	1.43	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	5.26	2.92	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	3.01	0.90	0.90	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	1.19	0.00	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.66	5.09	3.05	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.68	3.82	2.29	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	1.91	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.47	4.32	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.95	2.75	1.06	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.54	2.90	1.16	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	3.78	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	9.83	2.71	1.02	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	2.32	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.51	2.57	1.72	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	3.61	0.60	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.92	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.80	2.53	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.46	5.08	1.78	1.27	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	13.01	3.10	1.65	0.41	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	3.67	0.31	0.61	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	6.21	0.96	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.53	3.77	2.66	0.00	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	3.05	4.58	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	3.88	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.83	3.97	1.85	1.06	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.81	4.72	1.09	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	5.77	0.61	0.86	0.49	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	5.65	1.88	0.68	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	2.31	0.84	0.42	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	14.64	3.49	1.74	0.70	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	14.72	2.91	2.10	0.65	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	17.00	5.22	1.79	0.60	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	31.42	9.29	4.01	1.03	1.03	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	29.69	8.64	4.64	0.75	1.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	28.90	8.65	4.67	1.02	0.23	0.11
Basophils, donor1	12241-129G9	14.91	5.49	2.09	0.26	0.00	1.05
Basophils, donor2	12242-129H1	49.79	15.15	10.82	1.80	0.00	1.44
Basophils, donor3	12243-129H2	25.72	5.88	5.29	0.88	0.00	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	3.23	0.86	0.65	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.00	2.74	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	2.51	1.88	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.74	1.25	1.25	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.91	1.61	0.69	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	11.16	3.24	1.80	0.36	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	11.75	2.78	2.78	0.52	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	23.29	6.06	4.66	0.47	0.70	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.66	9.91	5.76	0.32	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	24.23	6.76	3.38	0.00	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	28.58	5.94	3.90	0.19	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	31.61	6.37	3.95	1.32	0.00	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.08	5.09	4.53	0.28	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	38.67	5.69	5.31	1.14	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.00	6.90	5.59	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	41.05	7.81	5.64	0.29	0.58	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	33.80	4.22	7.85	0.91	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	45.01	8.77	6.16	0.71	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.29	5.36	5.19	0.17	0.84	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	25.95	5.52	4.14	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	26.78	4.96	6.45	0.50	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	23.10	5.29	5.68	0.20	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	21.19	4.27	4.63	0.36	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	30.69	8.05	4.79	0.00	0.22	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	30.20	6.79	3.98	0.23	0.94	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	36.43	7.39	2.64	1.06	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	41.05	4.44	6.66	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	29.15	4.76	4.02	0.30	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	23.55	4.39	4.99	0.20	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	37.06	8.33	5.62	0.00	0.62	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.85	5.95	4.35	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	28.28	6.56	8.60	0.00	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.08	8.29	3.06	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.13	4.84	7.53	0.81	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	28.44	6.28	5.93	0.52	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	46.71	6.31	4.21	1.68	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	22.05	5.88	3.12	0.00	0.92	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.78	5.99	2.82	0.00	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.45	7.46	5.26	0.88	0.88	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.28	4.01	5.41	0.00	1.22	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.96	3.72	3.35	0.37	1.86	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	36.64	8.62	5.82	1.08	0.00	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.16	6.55	2.87	0.82	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	24.34	3.71	4.17	0.46	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	27.84	5.57	4.41	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	17.87	3.05	2.40	0.00	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	15.48	2.77	6.01	0.46	0.00	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	17.76	3.03	3.25	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	37.68	6.54	4.52	0.31	0.00	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	28.29	5.24	4.37	0.35	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	44.82	6.91	6.69	0.45	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	21.69	4.85	3.06	0.26	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	22.83	4.61	3.07	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	16.42	3.16	4.21	0.63	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	14.23	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.03	9.49	8.14	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	50.74	12.43	4.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	55.44	17.59	4.80	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	57.36	13.40	9.11	1.61	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.14	15.44	4.91	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	61.18	13.33	7.06	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	17.14	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	60.00	18.08	9.04	0.82	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	61.66	16.68	5.80	1.45	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	64.62	13.63	3.53	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	29.50	16.97	5.66	3.23	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	25.97	5.19	3.60	1.20	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	32.13	9.04	10.04	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	43.26	12.36	10.67	0.00	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	24.05	6.39	4.88	1.13	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.90	5.41	3.61	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	98.19	22.85	16.07	2.50	0.71	5.71
CD4+ T Cells, donor2	11306-117C1	74.71	20.21	12.25	0.61	2.45	5.51
CD4+ T Cells, donor3	11382-118B5	83.26	21.35	16.47	0.00	1.22	3.96
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	35.99	8.17	5.87	2.04	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	35.94	10.78	6.06	0.22	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	34.78	9.20	4.89	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	73.96	22.76	17.07	1.42	0.47	6.64
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.02	22.47	12.64	2.81	0.00	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	82.41	9.89	16.48	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.35	12.72	7.37	0.87	0.29	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	28.64	10.17	5.25	0.17	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	31.44	8.87	4.67	1.13	1.29	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.45	24.21	8.07	1.79	0.45	3.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	56.25	11.88	8.04	1.05	0.70	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	69.96	17.60	14.52	0.00	0.44	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	54.81	15.18	6.32	1.26	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.13	7.90	4.57	0.62	1.25	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	29.40	5.01	2.34	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	83.21	23.11	14.14	1.36	0.27	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	88.43	23.58	13.93	2.68	0.00	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	68.14	17.93	16.14	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	54.70	16.87	8.72	0.93	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	38.99	10.83	5.63	0.65	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	40.56	10.51	5.67	0.84	0.42	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	75.84	18.20	22.75	1.52	0.00	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	72.35	19.06	13.43	1.73	0.00	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	84.11	25.71	11.77	0.44	0.00	6.10
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	57.90	11.88	5.94	0.49	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	55.39	3.69	5.54	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	6.98	8.37	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	74.22	17.45	8.31	1.11	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	63.31	12.02	7.36	0.98	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	55.44	24.64	3.08	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	52.64	15.76	5.37	1.43	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	62.32	20.77	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	87.09	23.25	14.41	1.64	0.00	9.49
CD8+ T Cells, donor2	11307-117C2	89.73	19.90	18.77	1.13	3.38	7.51
CD8+ T Cells, donor3	11383-118B6	89.63	20.20	19.44	1.51	2.02	7.07
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.95	3.90	1.15	0.46	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.15	2.16	0.96	0.24	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.30	4.10	0.82	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.21	3.60	3.60	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.64	2.64	1.44	0.00	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.46	2.96	1.36	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.65	1.74	1.74	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.63	2.11	1.84	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.91	1.41	1.17	0.00	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.15	2.42	3.02	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	9.01	1.74	0.00	0.00	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.19	2.66	2.40	0.53	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.38	1.75	2.63	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.66	0.91	3.64	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	1.49	2.24	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.64	1.80	1.08	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.48	2.30	1.44	0.29	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.78	2.59	0.94	0.24	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.46	1.90	2.85	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	9.53	2.15	0.92	0.00	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.90	2.24	0.96	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.56	1.53	3.06	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	3.15	2.36	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	1.51	3.78	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	23.29	3.21	1.61	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.19	2.80	2.80	0.00	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	17.03	2.00	2.00	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	21.93	5.48	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.39	0.99	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	11.05	2.63	2.74	0.11	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	23.57	5.20	5.20	0.35	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	11.37	4.62	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	18.32	4.89	2.73	0.57	0.57	0.23
Chondrocyte - re diff, donor2	11339-117F7	12.53	8.95	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	29.52	3.64	5.26	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	25.94	6.20	2.75	0.92	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	14.96	4.28	2.14	0.43	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	16.11	3.72	1.59	0.44	0.62	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.93	11.46	1.83	2.48	0.00	0.09
Corneal Epithelial Cells, donor1	11526-119I5	2.85	0.66	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.56	2.05	0.26	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	17.17	5.12	2.15	1.32	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.66	6.94	3.15	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.96	2.92	1.84	0.32	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	53.98	6.83	6.49	1.37	0.68	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	48.31	7.18	7.18	0.00	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	66.30	7.74	7.74	0.97	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	5.34	3.34	1.00	0.17	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	3.52	1.76	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	6.22	1.13	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.22	4.33	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.24	1.45	0.58	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	9.65	2.82	2.82	0.00	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	5.79	2.80	1.93	0.18	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.07	4.88	1.77	0.22	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.86	4.87	2.74	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	24.53	2.82	4.23	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.05	0.30	0.59	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	4.17	0.00	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	2.84	1.42	0.43	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	11.60	3.60	2.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	0.52	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	23.73	8.57	3.60	0.50	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	13.04	3.04	1.74	0.43	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.07	4.76	3.42	0.37	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	10.24	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	4.19	2.10	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	9.26	2.36	1.41	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	60.99	0.00	15.25	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	183.18	49.51	18.15	4.95	0.00	3.30
Eosinophils, donor3	12246-129H5	85.60	24.97	10.70	14.27	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	1.71	0.73	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.88	7.39	5.34	1.23	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.49	2.63	0.99	0.55	0.00	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.67	3.68	1.52	1.08	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.92	7.28	3.88	0.61	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	35.48	17.74	5.87	2.18	0.27	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.91	3.80	2.43	0.21	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.09	10.54	6.59	0.53	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.62	5.32	3.32	0.33	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	8.62	4.54	1.36	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	13.64	4.55	0.76	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.20	2.68	1.10	0.32	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	23.95	8.49	3.64	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	16.75	4.06	3.17	0.00	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	15.92	3.34	2.88	0.61	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.71	2.14	2.14	0.27	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.00	6.47	3.88	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	2.93	1.46	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	5.54	1.15	0.92	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	19.00	4.41	3.56	0.68	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	14.79	5.87	1.41	1.41	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	6.60	3.30	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.85	3.87	1.57	0.36	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	13.90	3.96	2.37	0.68	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	14.83	4.71	3.66	0.17	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	19.00	4.39	3.09	0.81	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	24.99	7.70	2.92	0.42	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.03	6.81	6.03	0.79	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	16.08	5.01	2.64	0.40	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	25.43	3.67	4.06	0.58	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	6.23	8.31	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.39	5.81	2.11	0.35	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	28.53	8.57	4.21	1.25	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.28	5.27	3.92	0.95	0.27	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.00	8.12	1.06	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.64	7.17	3.51	0.88	0.15	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.68	9.00	4.36	0.68	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	31.59	10.86	4.17	0.88	0.22	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.59	9.68	5.28	0.59	0.59	0.00
Fibroblast - Lung, donor1	11270-116H1	4.08	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	2.98	5.97	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	8.65	3.38	2.32	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	0.83	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.74	2.44	1.62	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.79	5.04	2.13	0.78	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.36	4.40	4.10	1.06	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.35	10.71	9.49	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	17.55	3.43	3.43	0.00	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.77	5.67	3.51	0.27	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.67	5.10	4.41	0.93	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	12.38	3.76	1.88	0.44	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.08	2.64	0.81	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	2.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.07	2.37	3.16	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	45.05	8.53	8.73	0.40	0.60	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	20.78	3.91	3.02	0.53	0.71	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.83	6.31	1.38	0.00	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.69	7.52	5.72	1.20	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.50	5.07	5.61	0.65	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	51.37	6.33	7.85	2.02	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	16.90	3.77	3.12	1.31	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	43.11	12.23	7.42	3.21	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	19.29	5.73	4.72	1.11	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	46.54	12.09	12.09	1.51	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.11	4.06	3.40	0.50	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.79	5.30	5.13	0.34	0.51	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.11	7.88	5.25	0.99	0.66	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.32	4.47	4.26	0.85	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	12.65	3.20	2.02	0.84	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.10	3.76	1.73	0.47	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	34.86	6.10	1.74	2.61	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.55	5.37	2.77	0.87	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	17.44	7.81	2.34	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.70	5.11	4.34	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.95	6.12	2.30	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	11.49	1.91	1.91	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.12	6.56	1.14	0.57	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.51	6.62	1.93	1.93	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	22.38	4.79	2.28	0.91	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	15.26	2.77	1.78	1.98	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	24.85	4.23	1.32	1.32	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.40	6.85	4.89	0.98	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	12.38	8.40	1.33	0.88	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	21.62	4.10	2.83	1.13	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.15	4.43	2.46	1.23	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	13.16	3.76	2.42	1.07	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.73	2.48	2.97	0.62	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.00	2.35	2.21	0.42	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.59	2.64	1.42	1.02	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	13.23	4.56	2.05	0.46	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.44	5.11	1.49	0.50	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.11	4.59	2.40	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.05	2.95	2.36	0.59	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.14	3.97	2.07	0.32	0.95	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.87	4.02	1.79	0.67	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	15.12	1.41	1.21	0.40	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	18.49	3.22	3.05	0.68	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.21	6.21	3.46	0.98	0.09	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.49	6.14	3.02	1.35	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.10	5.46	4.44	0.34	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.56	3.54	1.99	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.80	5.82	2.41	1.33	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.03	5.51	3.06	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.95	2.89	1.24	1.03	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.71	2.88	3.34	0.58	0.23	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.84	3.50	1.50	0.83	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.37	5.29	1.54	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.44	4.18	3.57	0.49	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.96	3.40	2.43	0.65	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.79	3.21	4.81	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.24	2.65	3.51	0.19	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.40	1.74	2.69	0.32	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.55	2.74	1.82	0.30	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.19	2.93	3.55	0.21	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.27	2.42	3.07	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.39	5.61	2.81	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.33	4.07	4.44	0.37	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.10	4.28	1.60	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.46	4.44	2.30	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.99	3.50	2.85	0.78	0.26	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	12.74	3.25	2.44	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.33	4.06	3.69	0.92	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	20.40	3.95	2.85	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	25.79	3.97	3.97	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.18	4.09	2.11	0.13	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.60	3.43	2.42	0.81	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	25.16	7.62	3.05	0.76	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	22.10	4.58	2.39	1.19	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	16.79	3.39	1.08	0.31	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	17.59	3.27	2.05	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	7.20	3.44	1.88	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	1.13	0.57	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	18.45	3.23	0.92	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	4.95	4.95	9.90	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.31	3.09	1.93	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	14.65	3.91	1.30	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.41	3.71	2.06	0.82	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	16.66	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	15.66	3.92	2.52	0.56	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.32	5.56	1.31	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	18.45	7.55	0.84	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	24.17	4.13	1.91	0.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	16.98	4.08	2.72	1.36	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	4.18	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	15.46	4.58	2.86	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.54	4.14	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	23.72	6.78	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.74	4.14	2.49	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.64	5.52	0.69	0.00	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.07	3.08	3.46	0.38	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	6.85	4.56	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	21.40	6.02	2.68	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.58	3.47	3.08	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.59	6.16	4.11	0.68	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	9.94	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	37.75	7.08	2.36	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	30.17	2.41	2.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.45	4.07	2.54	1.53	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.52	6.78	3.59	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.61	5.92	3.95	0.99	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	51.94	9.44	4.72	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	29.76	4.67	5.25	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	52.23	8.34	6.14	1.32	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	11.02	6.78	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	15.52	3.58	3.58	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	3.88	4.85	1.46	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	2.28	2.28	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.88	2.49	4.99	0.00	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	5.62	3.37	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.81	6.03	2.85	0.32	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.43	1.67	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.07	5.69	1.97	1.04	0.46	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.30	8.95	3.04	1.52	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.38	7.28	1.82	0.46	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.91	5.25	1.75	0.77	0.87	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.61	6.02	1.29	0.64	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.33	8.61	2.15	0.65	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.58	5.98	1.49	0.50	0.50	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.21	4.80	1.72	0.51	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.29	3.52	1.92	0.32	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	4.48	1.68	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.87	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.94	1.06	0.71	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	2.91	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.97	4.20	1.92	0.00	0.70	0.35
Hepatocyte, donor1	11523-119I2	20.58	8.47	2.42	0.00	1.21	1.21
Hepatocyte, donor2	11603-120I1	16.16	4.31	2.15	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	13.50	2.45	3.68	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	13.05	5.22	6.53	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.69	7.34	4.89	0.35	0.35	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.76	2.74	2.88	0.14	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	6.92	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	7.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	9.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	3.25	4.87	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	1.67	1.67	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	0.00	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.82	3.78	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	1.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	4.83	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.85	0.81	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.62	3.78	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	4.82	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.55	1.89	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	3.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	9.57	1.28	1.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	3.65	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.14	2.86	0.71	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2.78	1.23	0.93	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	0.00	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	5.23	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	6.75	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	6.97	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	2.13	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	6.93	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	1.84	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	1.06	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.69	4.57	1.55	0.65	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	4.69	1.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	12.68	4.83	2.37	0.38	0.47	0.00
Keratinocyte - oral, donor1	11251-116E9	17.71	7.38	3.18	1.25	0.34	0.00
Keratocytes, donor1	11527-119I6	4.81	3.09	1.38	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	2.34	0.00	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	16.99	3.36	3.16	0.20	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	2.16	5.39	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	15.45	2.31	1.38	0.46	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	20.28	6.46	4.94	0.91	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.15	1.07	0.59	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.63	0.28	0.84	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.85	3.15	3.15	0.47	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	2.15	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.10	0.63	0.95	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2.37	1.08	0.32	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.57	3.28	1.64	0.82	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.77	1.01	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.36	1.41	0.70	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	1.98	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.23	0.97	0.39	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.41	0.74	0.74	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	2.09	0.35	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.34	0.95	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.61	1.10	1.10	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	2.46	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.74	0.62	0.62	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.20	0.37	0.37	0.00	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	2.96	1.32	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.05	2.34	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.99	1.49	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.67	3.39	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.04	0.81	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.48	0.91	0.91	0.15	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.49	2.51	1.26	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	2.41	0.60	0.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	0.00	1.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.76	1.88	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.70	0.74	0.32	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.81	0.48	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.65	1.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.35	0.12	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.96	5.18	2.96	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.21	0.99	1.73	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.47	0.27	0.55	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	3.22	1.29	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.39	2.43	2.13	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.44	1.96	0.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	1.42	1.78	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.45	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.02	0.62	0.47	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	1.79	2.15	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.55	0.98	1.31	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.18	0.24	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.05	1.98	1.73	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.82	1.02	1.02	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.58	0.60	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	4.53	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	3.84	2.30	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	1.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	2.54	0.42	1.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	5.63	4.22	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	3.74	1.87	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.18	1.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	7.14	3.57	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.92	5.88	0.45	0.45	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.31	4.94	1.16	1.74	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.80	6.75	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.62	4.06	1.08	0.41	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	5.14	1.54	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.76	3.53	2.12	1.41	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	4.66	0.67	2.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	2.55	1.02	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.54	3.74	1.33	2.13	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.39	3.59	0.94	0.94	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	6.14	1.84	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.15	4.08	1.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.87	5.21	1.87	0.62	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.29	4.48	0.84	1.12	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	5.15	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.19	4.35	1.74	0.87	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.37	4.78	2.09	0.60	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.07	3.32	3.32	2.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.78	3.18	2.12	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.85	4.43	1.48	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.28	4.22	1.15	1.54	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.23	3.96	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	4.10	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	4.52	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	9.34	5.75	0.72	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	8.96	0.00	2.24	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.18	2.60	0.74	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.05	3.45	0.43	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7.71	5.99	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.99	4.66	0.67	2.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	8.45	4.22	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	4.98	0.71	2.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	3.44	0.69	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.27	1.07	1.61	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	1.35	1.35	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.85	3.70	0.74	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	3.49	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	1.06	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.80	4.80	1.20	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	1.45	1.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.20	5.37	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.88	4.44	0.00	0.99	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	9.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	3.02	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.91	5.86	1.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	1.72	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.47	4.01	1.34	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.21	5.08	1.17	1.17	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.88	1.98	1.32	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.05	6.23	2.59	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.06	3.94	0.88	1.31	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	3.91	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.95	4.86	1.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.96	2.31	0.77	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	4.56	2.53	1.01	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	6.25	5.77	0.96	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.34	5.57	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	4.86	1.22	1.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	4.84	0.69	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.44	4.56	1.90	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.78	3.10	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	9.67	1.81	2.42	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	6.34	4.44	1.27	0.32	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.46	4.26	1.07	2.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	4.60	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.31	5.14	0.51	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	7.07	2.12	0.71	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.11	5.67	1.70	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	5.82	1.66	0.00	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	3.92	0.00	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.69	5.01	0.42	0.00	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.36	4.18	2.32	1.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	4.01	1.34	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.09	3.74	1.07	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.89	4.45	0.81	0.81	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	4.59	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	7.11	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.26	2.85	2.85	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.97	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	3.83	1.64	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	10.69	4.90	0.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.48	3.38	0.52	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	2.65	1.99	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	6.24	2.08	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	18.46	4.56	3.19	0.91	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	10.83	3.30	2.57	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	14.16	3.01	2.49	0.00	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.68	4.78	1.59	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	18.54	5.07	3.01	0.63	0.48	0.48
Mallassez-derived cells, donor3	11930-125I4	14.59	4.17	3.20	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	14.65	13.55	2.59	1.40	0.30	0.10
Mammary Epithelial Cell, donor2	11350-117G9	15.64	8.98	3.19	1.45	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	5.24	1.00	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	128.81	65.76	48.81	3.39	0.68	6.78
Mast cell, donor1	11563-120D6	41.09	10.71	7.03	1.19	0.43	0.11
Mast cell, donor2	11565-120D8	101.04	27.93	10.40	3.57	0.00	2.08
Mast cell, donor3	11566-120D9	150.16	30.84	16.66	10.36	0.45	2.25
Mast cell, donor4	11567-120E1	86.69	24.47	11.88	3.19	0.18	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	46.91	9.32	4.88	0.67	0.67	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	64.21	17.51	1.75	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	36.94	7.00	3.33	0.80	0.57	0.23
Mast cell, expanded, donor8	11941-126A6	58.91	10.88	6.36	1.00	0.17	0.84
Melanocyte - dark, donor1	11502-119F8	10.75	2.59	2.49	0.10	0.30	0.00
Melanocyte - dark, donor2	11582-120F7	11.77	2.42	1.04	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	15.21	5.87	3.33	0.58	0.14	0.14
Melanocyte - light, donor1	11274-116H5	4.23	1.65	0.47	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	5.46	2.05	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	0.87	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	14.37	2.50	2.29	0.52	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	12.64	5.38	2.42	0.54	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	14.73	1.34	4.02	0.80	0.00	0.00
Meningeal Cells, donor1	11493-119E8	8.81	2.23	1.49	0.25	0.00	0.00
Meningeal Cells, donor2	11573-120E7	6.60	0.88	2.20	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	21.84	5.05	2.77	0.65	0.24	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.11	5.99	4.56	2.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	24.25	10.16	3.12	1.11	0.00	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	3.94	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	5.02	3.59	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.67	4.02	1.91	0.64	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	2.01	2.01	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.83	2.20	1.10	0.66	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.12	1.02	1.02	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.75	5.26	3.19	1.39	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.32	0.37	1.49	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	24.60	4.61	3.16	0.79	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.64	2.37	0.59	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	2.56	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.53	7.09	4.25	1.06	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.08	4.69	3.13	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	14.51	1.45	2.18	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	14.58	4.51	1.86	0.80	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	6.51	1.50	2.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.14	3.47	1.95	0.58	0.29	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	2.70	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.98	2.46	3.20	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.08	3.53	2.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.12	2.79	2.48	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.86	3.32	2.90	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.52	4.25	3.25	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.69	6.05	1.40	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.85	2.24	2.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.44	3.96	1.98	1.19	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	1.77	2.65	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	11.40	1.90	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	1.32	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.82	1.91	1.06	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	3.58	2.98	0.89	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.28	2.76	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.22	3.80	0.24	0.71	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	2.21	3.32	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.60	2.07	2.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.46	4.21	1.68	0.21	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.38	2.24	1.63	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.73	1.93	2.15	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.56	5.11	1.33	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.54	2.85	1.53	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	4.56	0.51	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.95	5.16	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	16.17	5.29	2.65	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	2.18	6.54	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.42	1.44	0.48	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	6.00	2.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	4.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	5.51	1.00	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.33	8.32	3.94	0.44	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	4.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	3.20	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	15.62	4.21	3.47	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	6.96	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	4.42	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.97	3.08	2.74	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	3.94	4.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.01	1.07	1.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.38	2.81	2.24	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	5.82	2.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	1.75	2.33	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	3.02	3.32	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	6.68	2.92	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	4.62	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.23	6.26	1.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.88	2.90	2.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	4.41	3.37	0.52	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.01	7.29	4.29	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	2.54	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.41	5.87	3.20	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	20.95	5.99	2.39	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.98	2.26	3.96	0.28	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.56	4.14	2.55	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.79	6.86	3.10	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	4.17	3.79	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.34	3.98	2.27	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.27	7.13	2.46	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	1.30	1.96	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.47	5.00	2.94	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.89	5.48	3.46	0.58	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.55	5.36	4.12	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.12	4.17	4.47	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.79	1.31	2.63	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	1.05	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.42	2.97	2.97	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.14	1.50	1.88	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.79	0.80	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.93	1.36	1.92	0.11	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	2.21	0.74	1.47	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.53	1.83	2.93	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	1.56	4.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	0.53	3.21	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	1.69	0.84	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	2.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.00	1.62	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	5.71	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	3.26	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.87	5.82	1.94	0.86	0.86	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	7.32	2.09	3.14	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	4.67	1.33	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	4.17	1.25	1.25	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.12	3.99	3.99	0.38	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	1.60	6.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	2.72	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	3.68	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.32	3.35	2.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	4.42	4.42	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	1.08	1.89	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.76	6.73	2.52	0.42	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	8.44	2.48	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.99	2.44	2.17	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.32	2.49	1.13	1.13	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.13	2.45	2.78	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.96	4.74	3.83	0.55	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	5.30	2.12	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	1.80	1.20	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.49	2.63	2.30	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	15.12	3.58	4.07	0.16	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.87	3.53	5.12	0.18	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	2.11	3.52	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.85	2.30	2.30	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.10	4.50	3.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	16.55	3.45	3.79	1.03	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	7.59	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.84	3.12	2.23	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.24	2.12	2.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.75	2.37	1.66	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.75	4.29	3.86	0.86	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.66	2.33	2.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	5.86	0.90	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.09	3.57	2.38	1.59	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	5.57	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.81	2.65	3.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.58	3.58	3.91	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	3.05	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.78	2.71	4.52	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	3.53	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.28	1.33	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	2.48	2.98	0.50	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.14	4.59	5.74	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.83	5.44	3.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.86	4.86	3.54	0.66	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	20.33	3.39	3.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	3.66	4.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.66	2.52	3.46	0.94	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.58	1.51	2.72	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.99	3.16	4.75	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	10.20	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	5.06	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	18.39	7.95	2.61	0.75	0.12	0.12
Myoblast, donor2	11322-117D8	24.17	6.33	3.84	1.73	0.77	0.00
Myoblast, donor3	11398-118D3	19.84	7.57	3.36	0.50	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	16.78	2.92	3.50	0.15	0.44	0.15
Natural Killer Cells, donor1	11230-116C6	74.42	21.83	16.61	0.92	1.85	5.23
Natural Killer Cells, donor2	11311-117C6	69.06	17.79	12.67	1.51	1.81	3.62
Natural Killer Cells, donor3	11387-118C1	83.38	18.22	11.60	0.92	2.21	3.68
Neural stem cells, donor1	11275-116H6	25.41	5.44	4.72	2.54	0.00	0.36
Neural stem cells, donor2	11352-117H2	44.29	15.41	3.85	0.00	0.00	0.00
Neurons, donor1	11494-119E9	19.34	3.41	4.55	3.41	1.14	1.14
Neurons, donor2	11574-120E8	18.93	2.42	1.54	1.10	0.44	0.44
Neurons, donor3	11655-122E8	14.80	2.47	3.29	1.64	1.64	0.82
Neutrophils, donor1	11233-116C9	126.21	38.05	10.21	5.57	2.78	0.93
Neutrophils, donor2	11314-117C9	110.16	23.19	5.80	5.80	2.90	0.00
Neutrophils, donor3	11390-118C4	182.03	37.26	14.05	6.72	1.22	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	25.65	11.40	4.04	1.78	1.07	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	9.12	3.91	2.60	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	12.63	2.01	1.60	0.60	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	17.48	3.58	2.62	0.14	0.96	0.28
Olfactory epithelial cells, donor2	11934-125I8	15.05	3.76	3.76	0.72	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	17.93	3.29	2.84	0.57	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	26.49	6.23	3.99	0.29	0.39	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	22.87	4.81	4.21	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	11.91	4.04	1.49	0.85	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	0.00	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.28	4.34	1.86	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	5.28	1.76	0.00	0.59	0.00	0.00
Osteoblast, donor2	11354-117H4	24.58	8.43	10.53	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	17.42	4.27	2.13	0.53	0.18	0.71
Pancreatic stromal cells, donor1	11249-116E7	20.64	6.23	3.29	0.84	0.42	0.08
Pericytes, donor1	11491-119E6	4.45	0.56	0.11	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	6.56	2.04	0.23	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	5.90	1.63	0.81	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	21.59	4.52	2.26	0.90	0.11	0.23
Perineurial Cells, donor2	11579-120F4	17.94	5.43	3.13	0.37	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	58.65	12.43	6.69	1.59	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	47.99	11.51	7.35	1.96	0.00	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	48.92	7.89	8.67	0.52	0.26	1.55
Placental Epithelial Cells, donor1	11278-116H9	12.91	3.59	0.72	0.72	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	8.87	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.89	1.37	0.39	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.91	1.58	1.58	0.00	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	16.88	7.32	2.63	0.38	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	37.07	9.53	7.44	1.17	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	16.21	5.85	3.38	0.45	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	16.20	7.78	2.13	1.60	0.00	0.21
Preadipocyte - omental, donor2	11329-117E6	21.39	4.80	2.62	0.00	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	15.04	5.73	2.29	0.43	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.67	7.68	0.92	0.92	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	24.44	10.80	4.07	0.71	1.42	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	18.39	6.98	3.75	0.85	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	23.75	9.50	4.47	1.49	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	21.17	10.58	4.14	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.78	5.12	2.61	0.42	0.21	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.95	8.00	3.02	0.75	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	11.65	5.96	1.90	0.81	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	14.02	6.86	1.47	0.80	0.37	0.06
Prostate Stromal Cells, donor1	11254-116F3	11.16	8.20	2.39	0.80	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	15.96	6.99	2.51	0.36	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	11.05	4.38	1.56	0.21	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	0.36	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.48	3.47	1.59	0.55	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	3.04	1.01	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	11.65	6.03	1.80	0.53	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.37	0.81	0.40	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.88	4.66	2.22	0.22	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	4.84	1.32	0.66	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	1.25	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.16	0.83	0.55	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	5.91	2.42	0.27	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1.27	1.27	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.31	0.96	0.39	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.45	3.89	0.00	0.52	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.55	0.85	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	11.79	6.02	1.76	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	41.16	7.08	6.55	0.53	0.13	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	0.89	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.01	2.75	2.75	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	18.56	2.90	2.90	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	10.27	2.08	2.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	7.25	1.29	1.69	0.10	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	11.38	1.45	1.23	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	10.42	0.99	1.86	0.12	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.04	1.05	1.63	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	10.40	1.39	2.31	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.08	1.64	0.96	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.32	1.06	1.82	0.00	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.75	2.33	1.97	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.74	1.86	2.01	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.55	1.07	0.97	0.21	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	6.42	1.11	2.21	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	9.56	1.34	1.15	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.52	0.84	1.58	0.00	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	13.53	2.25	1.13	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	8.36	1.33	1.06	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.50	0.97	1.95	0.29	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	8.59	0.76	1.53	0.00	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	9.08	0.96	2.56	0.43	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	4.77	0.56	1.96	0.00	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.25	1.37	2.39	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.58	2.01	1.82	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.71	1.10	1.84	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	6.85	1.61	1.88	0.40	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.43	1.89	2.12	0.47	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	5.56	2.18	0.99	0.20	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.03	0.94	0.94	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.88	2.07	2.07	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.41	0.88	0.88	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	10.03	1.67	0.84	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.90	1.62	1.75	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	10.05	2.21	1.19	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	10.99	2.31	1.74	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.83	1.55	0.86	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	10.29	1.37	0.55	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.84	1.97	1.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.54	0.68	1.19	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	5.33	1.18	1.63	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	9.86	1.87	1.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.74	1.52	2.07	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.76	1.19	1.43	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.54	2.02	1.81	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.97	0.57	1.88	0.09	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.48	0.00	1.75	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	10.88	0.91	1.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.55	1.35	2.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	22.85	3.78	3.06	0.15	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.30	1.83	3.04	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.95	1.51	0.90	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	9.73	1.36	1.13	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.98	1.20	2.10	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.44	1.42	1.65	0.35	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	7.90	1.49	2.56	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	10.22	1.20	8.41	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	5.08	1.69	0.56	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.46	4.60	0.66	0.00	0.22	0.00
Sebocyte, donor1	11220-116B5	2.74	1.64	1.64	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	2.30	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	4.33	0.41	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	24.85	3.31	6.63	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	25.42	2.82	0.00	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	9.85	3.61	1.58	0.53	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	13.01	2.17	2.17	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	13.38	4.18	3.34	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	13.98	4.56	2.67	1.10	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	16.65	4.46	3.12	0.59	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	16.93	4.77	2.92	0.46	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	27.97	6.68	3.78	0.76	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	21.12	5.42	1.43	0.57	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	18.65	5.75	3.17	0.99	0.10	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.13	3.71	2.61	0.42	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	2.17	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.84	0.96	0.96	0.28	0.00	0.00
Skin - palm, donor1	10286-104F7	32.23	8.06	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.23	3.17	1.59	0.58	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	54.80	13.09	7.36	1.64	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.00	2.08	2.34	0.39	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	16.26	6.53	1.81	0.56	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	10.83	3.94	1.97	0.00	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	56.24	23.26	9.30	1.48	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	17.61	6.52	2.70	0.52	0.30	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.64	4.32	0.62	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.79	5.56	6.89	1.56	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.40	11.17	3.53	0.59	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.85	3.09	1.33	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	2.76	1.18	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	13.13	4.64	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	18.01	4.00	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.18	3.59	1.20	0.13	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.51	9.31	3.55	0.89	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.80	5.76	3.33	1.15	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.61	5.54	1.63	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.04	7.38	5.32	1.18	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.23	3.84	2.42	0.57	0.00	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.79	0.33	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.61	3.65	3.35	0.61	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.36	4.55	1.52	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	3.34	4.77	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.02	6.64	2.36	1.03	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.85	3.44	3.01	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.64	5.25	3.15	0.84	0.21	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.12	3.40	1.08	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	2.16	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.87	1.20	1.49	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.66	5.18	2.91	0.63	0.39	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	24.15	13.99	2.31	2.01	0.30	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.11	12.52	2.50	1.37	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	1.21	1.81	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	19.87	12.72	5.83	0.79	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	21.84	6.52	3.33	1.46	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	14.53	7.51	2.38	1.13	0.88	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.43	5.58	3.55	1.27	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.57	6.78	2.56	0.45	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.75	1.50	1.50	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	6.98	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.20	9.59	3.03	0.50	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	13.16	5.01	2.51	0.31	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.33	8.91	4.33	1.33	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	13.55	2.80	1.87	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.04	3.60	0.86	0.72	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.47	4.84	2.04	0.25	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.02	2.07	1.88	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	17.75	6.01	3.35	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.67	4.11	2.77	0.50	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	1.90	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	2.45	0.98	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	23.64	7.73	4.42	0.66	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.09	4.39	1.76	0.88	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.58	2.72	3.69	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.05	5.29	1.85	0.00	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	2.23	1.86	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	6.11	3.23	1.80	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.22	7.38	2.27	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	3.15	0.79	0.00	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	13.71	4.06	1.78	1.27	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	19.57	2.80	1.60	2.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	11.29	5.02	2.09	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	5.04	1.83	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	29.96	8.92	3.87	0.67	1.01	0.34
Synoviocyte, donor2	11368-117I9	16.93	5.70	3.18	0.84	0.50	0.00
Synoviocyte, donor3	11440-118H9	15.19	4.24	2.23	0.67	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	4.65	1.07	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.63	1.39	1.16	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	5.23	3.37	0.65	0.50	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	5.41	2.32	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	43.80	7.75	5.04	1.23	0.37	0.12
Urethra, donor2	10319-105A4	59.35	10.79	1.80	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	1.86	0.53	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	0.40	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.81	0.46	0.46	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	30.76	5.57	5.35	1.11	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.94	11.57	3.56	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	52.90	7.15	8.58	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.07	8.90	5.48	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.55	10.33	2.75	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	32.54	11.62	0.58	2.91	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	44.77	8.33	8.33	3.12	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	47.73	10.10	11.01	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.04	9.13	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	11.47	4.07	2.47	0.25	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	13.20	0.88	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.61	3.07	1.40	0.84	0.00	0.28
achilles tendon, donor2	10292-104G4	20.67	2.07	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.24	2.04	0.76	0.00	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.43	5.34	2.79	0.23	0.70	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	16.98	4.04	1.78	0.24	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	22.86	11.43	2.72	1.36	1.63	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.62	3.65	2.81	0.00	0.84	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	22.42	9.73	4.02	0.85	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.97	2.72	1.91	0.54	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.56	4.85	4.41	1.32	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.42	3.68	2.04	0.82	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	17.86	5.05	3.11	0.39	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	12.70	2.39	1.47	0.37	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.08	4.65	2.09	0.93	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	23.82	5.70	3.11	0.26	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	17.53	5.26	2.34	0.58	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	8.83	6.04	0.46	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	27.55	2.06	2.88	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	16.58	3.68	2.46	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	13.65	8.53	2.56	0.00	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	23.05	11.83	4.25	0.61	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	26.00	8.42	3.37	1.20	0.00	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.46	2.67	0.89	0.22	0.45	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.34	5.00	2.00	1.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	18.58	3.72	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	5.27	2.64	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	13.08	3.49	2.62	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	3.75	5.62	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	28.50	1.88	3.77	0.47	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	27.30	5.89	2.64	0.47	0.31	0.00
adipose, donor1	10184-103D4	22.87	6.45	1.76	0.59	0.00	0.00
adipose, donor2	10185-103D5	35.28	15.82	3.24	6.49	0.00	0.00
adipose, donor3	10186-103D6	19.33	7.90	3.81	0.82	1.09	0.54
adipose, donor4	10187-103D7	6.93	3.47	1.73	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	11.05	3.31	1.42	0.47	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.68	5.87	2.13	1.20	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.22	2.50	2.50	0.71	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	40.57	8.35	3.48	1.62	0.46	1.16
amniotic membrane cells, donor2	12236-129G4	29.41	5.41	4.06	1.69	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	38.89	8.54	3.54	2.65	1.18	0.59
amygdala - adult, donor10196	10167-103B5	22.53	3.56	2.37	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	30.42	8.11	4.06	2.84	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	22.27	6.13	2.26	5.81	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	53.61	13.24	4.58	0.76	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	14.78	2.43	3.75	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	23.72	4.01	4.01	1.00	0.33	0.00
aorta, adult, pool1	10052-101G7	19.42	4.12	2.75	0.39	0.39	0.39
appendix, adult	10189-103D9	32.21	8.93	4.66	0.39	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	21.32	8.94	4.47	0.00	0.34	0.00
artery, adult	10190-103E1	21.74	2.72	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	24.63	7.82	6.08	0.72	0.43	0.29
b cell line:RPMI1788	10427-106D4	48.18	9.81	7.58	0.45	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	27.19	4.16	5.27	0.55	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	13.89	6.85	2.58	0.50	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	22.43	11.05	5.86	1.00	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.01	3.91	3.91	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	44.33	8.26	3.04	1.09	0.43	0.11
blood, adult, pool1	10053-101G8	11.07	4.43	6.64	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.98	4.28	5.99	0.00	0.00	0.00
bone marrow, adult	10192-103E3	33.74	3.37	2.02	0.00	0.67	0.67
brain, adult, donor1	10084-102B3	19.48	4.10	1.03	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	24.94	6.01	4.12	3.12	0.33	0.22
brain, fetal, pool1	10085-102B4	10.69	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	23.13	8.26	3.30	1.65	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	40.82	17.23	3.12	2.37	0.25	0.00
breast, adult, donor1	10080-102A8	33.46	4.42	3.79	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	7.24	5.84	2.03	0.76	0.38	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	14.84	4.33	1.24	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.33	10.59	3.22	0.69	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.44	3.39	0.73	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	18.34	0.47	3.29	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	23.95	8.42	5.69	0.33	0.00	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	16.80	1.90	0.63	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.82	3.99	3.73	0.80	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	31.09	5.76	2.30	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	25.77	6.86	4.02	2.84	0.50	0.00
caudate nucleus, adult, donor10258	10379-105H1	22.92	4.58	1.53	4.58	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	28.57	8.42	1.10	4.03	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	72.83	8.74	5.83	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	77.93	9.82	6.62	3.42	0.85	0.00
cerebellum, adult, pool1	10083-102B2	29.32	3.10	1.38	1.03	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	72.23	8.30	2.49	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	31.52	7.31	4.79	2.52	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	15.35	2.92	0.73	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	13.66	3.31	2.16	0.43	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	22.37	9.61	3.65	0.50	0.17	0.00
cervix, adult, pool1	10013-101C4	48.30	7.35	4.20	1.15	0.52	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.81	7.11	2.79	1.11	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	27.71	8.33	2.98	0.75	0.75	0.12
choriocarcinoma cell line:SCH	10785-110H2	10.10	7.15	2.22	0.49	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	15.42	4.03	2.13	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	37.89	6.55	4.84	0.57	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	31.82	7.26	5.47	0.70	0.50	0.30
chorionic membrane cells, donor3	12240-129G8	38.46	3.85	3.30	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	5.05	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.41	4.03	3.07	0.00	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.50	4.01	2.96	1.27	0.21	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	15.15	6.42	1.54	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.93	3.87	2.42	0.24	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.16	6.52	1.63	1.22	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	11.78	5.30	2.06	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	16.94	6.52	8.08	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	10.29	2.97	2.74	0.46	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	33.14	10.76	5.21	0.87	0.87	0.35
colon carcinoma cell line:CACO-2	10513-107D9	21.42	8.42	3.66	0.18	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	31.93	4.56	4.18	0.38	0.00	0.38
colon, adult, donor1	10082-102B1	23.80	1.19	3.57	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	45.12	10.22	6.46	1.29	0.24	0.24
colon, fetal, donor1	10070-101I7	44.50	8.03	3.09	4.33	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	100.84	55.00	18.33	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	30.60	9.77	9.35	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	16.00	4.23	2.72	0.75	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	19.74	5.64	3.67	0.00	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	21.56	8.07	3.43	3.43	0.11	0.00
cruciate ligament, donor2	10295-104G7	26.75	8.10	4.05	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	21.67	1.61	2.41	0.00	0.80	0.00
diencephalon, adult	10193-103E4	24.48	6.24	2.64	1.92	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.09	2.53	1.84	0.46	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	54.11	22.57	8.98	3.59	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	8.91	4.33	1.69	0.72	0.48	0.00
ductus deferens, adult	10196-103E7	53.82	15.45	3.49	1.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	8.64	5.76	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	11.77	3.68	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	39.64	8.42	4.46	4.46	0.00	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	18.88	16.21	6.44	0.44	0.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	7.88	5.59	2.01	0.43	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	22.20	6.17	3.08	0.00	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	20.58	4.24	3.63	0.30	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.40	8.03	6.17	0.00	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	19.70	6.57	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	43.91	10.39	5.03	1.68	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.73	3.99	5.07	0.91	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.38	4.18	2.09	0.32	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	15.01	6.22	3.33	0.78	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	16.17	5.61	3.41	0.55	0.00	0.11
epididymis, adult	10197-103E8	45.84	12.35	4.81	3.77	0.42	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	19.87	7.27	3.02	1.24	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.12	1.18	2.75	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.70	4.98	2.10	0.52	0.39	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	12.20	6.99	2.66	0.39	0.59	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	11.76	5.94	2.02	0.45	0.56	0.11
esophagus, adult, pool1	10015-101C6	25.16	5.63	2.76	0.74	0.42	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	39.83	10.27	4.01	1.88	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	41.05	7.24	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	18.34	3.44	2.29	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	29.15	2.91	5.83	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	32.29	4.32	4.32	0.51	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	7.44	2.44	1.80	0.26	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.35	9.97	2.61	1.19	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	32.74	7.79	4.60	3.75	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.51	3.90	2.70	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	35.02	4.85	4.57	0.18	0.09	0.09
gall bladder, adult	10198-103E9	31.87	7.24	3.38	0.24	0.00	0.72
gamma delta positive T cells, donor1	11937-126A2	54.22	8.59	8.05	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	56.02	7.10	4.11	0.37	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.52	2.75	3.17	0.42	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.85	6.58	4.26	0.19	1.35	0.00
gastric cancer cell line:AZ521	10549-107H9	16.23	4.59	2.79	0.00	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	21.97	2.75	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	29.70	6.17	6.85	1.37	1.60	0.23
giant cell carcinoma cell line:LU65	10487-107B1	13.31	4.02	0.92	0.23	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	23.23	12.74	2.94	1.54	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.70	7.98	2.99	1.00	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	20.48	5.28	3.91	1.16	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.47	6.32	3.51	0.84	0.28	0.42
glioblastoma cell line:T98G	10485-107A8	20.42	4.75	4.53	0.11	0.11	0.11
glioma cell line:GI-1	10413-106B8	24.02	4.10	4.98	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	29.89	8.02	2.92	3.64	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	41.98	11.96	7.08	2.93	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	31.49	12.32	2.74	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	17.59	12.26	1.07	3.20	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	24.47	14.68	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.72	2.56	2.24	0.64	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	11.94	3.67	0.92	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	9.15	2.29	1.37	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	13.53	3.22	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	18.68	5.75	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	13.72	1.37	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	20.97	9.93	2.21	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	13.22	6.03	1.44	0.86	0.29	0.29
heart - mitral valve, adult	10205-103F7	41.86	4.19	2.39	0.90	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	24.58	4.45	2.35	1.31	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	44.13	9.16	1.67	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	13.67	2.86	2.04	0.20	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	11.50	0.43	1.28	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	36.57	3.22	1.84	1.15	0.00	0.46
heart, fetal, pool1	10046-101G1	46.72	4.42	4.00	0.41	0.31	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.08	4.32	4.01	0.93	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	0.00	5.95	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	22.32	6.63	6.08	0.22	0.55	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	23.67	7.40	6.19	0.61	0.73	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	26.07	5.86	5.36	0.00	0.61	0.61
hepatoma cell line:Li-7	10484-107A7	16.79	7.45	3.89	0.11	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.04	2.61	1.81	0.20	0.50	0.00
hippocampus - adult, donor10196	10169-103B7	23.66	6.62	4.73	3.79	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	31.43	10.20	3.47	3.06	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	22.91	7.47	3.98	1.99	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	21.85	4.93	1.06	2.11	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	9.77	3.66	2.44	1.83	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	10.80	2.55	0.20	0.39	0.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.16	6.35	1.27	1.78	0.51	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	16.92	1.13	2.82	1.69	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	15.23	4.65	1.81	1.29	1.55	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	14.80	4.18	1.14	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	27.15	5.55	2.63	0.58	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	26.71	7.11	2.80	1.94	1.08	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.69	5.84	0.83	0.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.89	7.58	3.08	1.18	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.80	4.98	3.05	0.48	0.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	21.55	5.39	2.02	2.02	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.21	3.91	1.10	0.63	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	10.81	5.40	1.97	0.49	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	11.35	6.11	0.87	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	23.48	6.68	2.29	0.95	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.80	6.11	0.87	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.49	6.00	1.00	1.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	32.40	11.68	2.07	5.27	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.74	10.91	1.82	3.64	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	34.46	11.90	2.82	4.39	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.66	4.41	1.14	0.98	0.82	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.29	6.39	2.03	0.00	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.34	5.38	2.69	1.49	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.42	4.25	0.74	0.74	0.74	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.13	2.57	1.71	0.57	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	12.25	2.86	1.63	1.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	18.66	5.99	1.06	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.04	5.07	0.32	0.95	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.53	4.24	1.21	1.51	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	25.34	7.76	2.07	2.59	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.21	13.95	0.66	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	23.34	8.21	1.03	2.05	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.43	4.86	2.30	0.77	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	6.82	0.76	0.00	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	15.79	7.73	2.69	1.01	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.42	3.62	1.69	0.00	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	14.26	2.67	0.45	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	14.15	5.85	0.98	1.46	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	15.59	6.42	0.31	1.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	16.27	3.25	6.51	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	15.55	5.63	1.32	1.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.01	7.11	2.19	4.93	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	23.88	5.79	1.09	2.90	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.40	9.25	3.20	2.85	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	7.16	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.00	8.13	4.33	1.76	0.14	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.09	5.93	2.16	1.08	0.00	0.00
immature langerhans cells, donor1	11904-125F5	62.23	27.85	10.41	1.94	0.73	2.91
immature langerhans cells, donor2	11905-125F6	45.15	9.51	5.54	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	19.12	5.77	2.65	2.65	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	8.45	1.30	2.60	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	30.74	11.01	4.41	1.20	0.30	0.30
kidney, fetal, pool1	10045-101F9	27.66	5.45	3.25	1.06	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	31.67	14.91	8.95	1.28	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.92	1.38	1.66	0.55	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.83	15.60	2.57	1.28	0.18	0.37
left atrium, adult, donor1	10079-102A7	14.71	1.09	2.18	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	20.73	1.01	1.52	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	14.77	3.56	2.19	0.27	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	6.11	2.87	0.72	0.72	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	5.43	3.26	0.54	0.54	2.17	0.00
leiomyoma cell line:15425	10571-108B4	7.53	4.86	1.70	0.49	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	1.05	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	15.47	5.78	6.85	0.59	0.59	0.35
liposarcoma cell line:KMLS-1	10782-110G8	22.65	5.15	3.91	0.31	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	14.38	2.19	3.05	0.37	0.00	0.00
liver, adult, pool1	10018-101C9	24.47	6.81	3.24	0.97	0.16	0.16
liver, fetal, pool1	10086-102B5	8.47	2.82	0.94	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	21.87	7.00	3.06	3.79	0.44	0.58
locus coeruleus, adult, donor10252	10165-103B3	27.13	9.04	3.88	1.85	0.74	0.18
locus coeruleus, adult, donor10258	10375-105G6	12.98	6.21	2.26	1.41	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	26.92	6.73	2.94	2.10	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	18.82	3.46	3.74	0.55	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	29.64	3.45	2.76	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.65	8.44	9.49	0.53	0.66	0.40
lung, adult, pool1	10019-101D1	42.64	12.05	3.54	2.60	0.35	0.24
lung, fetal, donor1	10068-101I5	113.02	25.97	10.27	4.28	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	34.37	8.25	3.67	1.37	0.00	0.00
lymph node, adult, donor1	10077-102A5	26.03	2.84	4.73	0.95	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	20.60	3.95	6.58	0.22	0.44	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.89	2.87	2.11	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	14.44	15.29	5.10	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	31.52	3.55	3.11	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	38.81	5.19	3.11	0.83	0.00	0.42
mature adipocyte, donor3	12233-129G1	28.92	4.74	3.32	0.95	0.00	0.24
mature adipocyte, donor4	12234-129G2	36.32	5.00	5.00	1.32	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.27	13.10	7.86	1.19	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	6.77	4.51	2.26	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	38.62	11.03	3.86	1.84	1.10	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	19.06	6.99	1.59	2.54	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	28.15	4.69	2.56	1.71	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	25.31	5.40	3.21	3.04	5.23	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	34.80	10.40	3.40	1.91	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	3.85	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	28.71	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.15	6.46	1.08	2.87	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	27.91	8.44	3.89	3.89	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	34.52	8.51	4.33	2.94	1.08	0.00
medulla oblongata, adult, pool1	10038-101F2	15.67	5.06	2.04	2.61	0.00	0.16
medulla oblongata, newborn, donor10223	10361-105F1	28.82	7.29	1.74	3.47	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	15.28	7.53	2.21	1.11	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	9.54	3.06	1.96	1.35	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	14.52	6.18	3.45	0.29	0.00	0.14
melanoma cell line:G-361	10465-106H6	17.92	5.16	2.17	0.81	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	15.38	5.79	1.81	0.72	0.90	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	21.15	3.52	7.93	0.00	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	20.22	4.41	3.63	0.52	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.09	6.90	4.91	0.46	0.61	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.54	5.82	5.09	0.55	0.73	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.05	6.21	1.66	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.42	3.37	3.23	0.14	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.91	2.50	3.27	0.19	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	23.60	6.25	2.78	1.39	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.84	5.32	2.57	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.30	4.26	3.22	0.46	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.66	5.31	3.32	0.66	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.56	6.08	2.84	0.54	0.54	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	19.35	5.69	5.55	0.14	0.71	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.77	8.23	4.61	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.94	4.70	4.70	0.69	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.15	3.84	1.75	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.52	3.06	3.27	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.25	7.19	1.80	1.08	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	17.69	3.52	1.34	0.52	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.14	5.93	3.19	0.46	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.14	7.97	4.62	1.68	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.37	6.13	4.93	1.20	0.75	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.76	2.80	3.50	0.35	0.44	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.41	2.21	1.10	0.37	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.60	7.15	2.58	0.86	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.95	3.79	3.79	0.84	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.44	2.28	4.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.32	4.09	1.79	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.66	8.64	3.14	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	4.31	2.46	0.92	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.30	6.59	1.88	0.94	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.22	4.74	3.38	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.79	3.14	3.14	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	3.24	2.32	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	3.75	4.90	1.15	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.62	4.46	2.01	0.45	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.51	6.25	3.36	1.44	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.20	5.87	3.67	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.43	4.70	1.68	0.67	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.74	5.32	1.64	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.46	4.30	2.58	0.43	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	13.67	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	5.16	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.24	4.55	3.25	1.30	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	4.36	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	5.86	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	4.91	3.27	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	8.55	3.50	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	6.30	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	7.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	14.30	4.77	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	7.12	2.96	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	2.44	3.66	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	4.43	1.90	1.90	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.21	4.83	1.03	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00	10.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.26	3.26	1.63	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	0.79	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.20	4.13	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	3.12	1.56	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	4.01	5.35	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	2.37	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	2.75	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.40	3.46	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	2.24	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.18	0.64	1.91	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.24	1.21	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.39	7.28	0.61	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	7.41	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	14.29	2.18	2.18	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.79	1.95	2.60	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	3.06	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.08	8.51	8.51	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	53.15	14.41	5.91	0.94	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.94	15.06	7.65	1.85	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.21	1.03	0.72	0.10	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	6.35	3.86	1.59	1.36	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	12.22	3.42	1.71	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	17.49	5.54	2.21	0.89	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	13.67	4.73	4.20	0.00	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	21.96	7.66	2.72	0.51	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	5.56	0.76	0.25	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	13.25	2.48	0.62	0.41	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	8.78	3.64	0.83	0.00	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	5.97	1.45	1.45	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	33.31	7.69	4.27	0.68	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	42.50	11.20	4.83	1.78	0.51	0.25
mesothelioma cell line:No36	10857-111G2	9.13	5.22	1.96	1.30	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	10.84	4.06	1.63	0.27	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	19.00	4.99	2.88	0.38	0.58	0.38
migratory langerhans cells, donor2	11902-125F3	24.79	4.88	2.93	0.61	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	33.92	7.90	5.03	0.54	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.59	4.24	2.61	0.33	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.60	2.76	3.39	0.42	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	18.20	5.30	4.61	0.69	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.28	1.90	3.62	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	22.73	5.91	4.25	0.55	0.37	0.37
myeloma cell line:PCM6	10474-106I6	18.78	2.77	3.36	0.00	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	11.67	2.03	2.54	0.51	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.58	6.67	6.47	0.20	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.15	6.46	2.12	0.67	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.40	7.06	1.84	0.74	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	9.94	3.86	1.10	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	33.82	5.52	8.05	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	20.77	4.30	3.37	1.12	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	8.86	1.27	0.84	0.21	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	24.60	4.29	3.54	0.75	0.56	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.25	3.56	3.32	0.47	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.27	4.12	2.06	0.63	0.79	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	6.24	2.01	1.81	0.20	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.72	2.54	0.64	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.17	1.86	5.59	0.27	0.27	0.53
neutrophil PMN, donor1	12133-128D9	89.25	44.62	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	76.10	21.31	4.74	2.88	0.68	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	2.40	4.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.16	5.45	5.45	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	15.50	5.26	4.20	1.31	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	20.25	5.53	3.56	1.97	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	41.21	0.00	2.06	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	43.74	10.73	4.56	3.49	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	29.48	7.28	2.91	2.55	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	28.60	3.94	3.15	2.36	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	45.91	1.72	6.44	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	14.90	4.02	2.37	1.58	0.00	0.08
olfactory region, adult	10195-103E6	18.91	6.11	3.82	2.10	0.96	0.38
optic nerve, donor1	10277-104E7	50.03	6.00	14.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.45	6.26	3.99	0.80	0.23	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.19	3.85	1.51	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.48	6.94	2.03	1.52	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.85	4.16	2.54	0.69	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	25.58	7.35	3.53	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	24.29	3.74	10.28	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	18.03	4.45	1.91	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	37.12	8.30	2.88	1.14	0.17	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.60	2.93	3.12	0.18	0.37	0.18
pancreas, adult, donor1	10049-101G4	18.81	7.53	2.82	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	15.09	4.47	2.80	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	19.76	11.07	4.26	0.34	1.53	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	22.68	6.95	4.97	0.50	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	18.76	5.86	3.11	1.74	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	24.96	4.40	0.73	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	23.51	9.40	1.88	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	32.49	9.69	5.42	3.71	1.43	0.00
parietal lobe, adult, pool1	10034-101E7	17.62	4.93	1.85	1.94	0.00	0.26
parietal lobe, fetal, donor1	10072-101I9	53.34	0.97	0.97	0.97	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	30.28	11.22	3.36	4.11	0.75	0.37
parotid gland, adult	10199-103F1	38.85	9.25	1.85	0.62	0.62	0.62
penis, adult	10200-103F2	32.76	2.15	3.22	2.15	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	30.31	3.35	1.49	1.30	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.66	4.37	2.62	1.17	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	42.57	12.26	4.52	1.29	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	75.80	14.81	14.21	3.55	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	23.20	8.78	1.25	1.25	0.63	1.88
pituitary gland - adult, donor10196	10180-103C9	81.96	21.25	11.13	1.01	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	136.55	27.62	19.28	4.17	2.61	2.08
pituitary gland, adult, donor10258	10378-105G9	48.52	21.28	16.17	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	52.03	7.31	9.68	0.54	0.75	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	15.36	4.77	2.38	0.13	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	56.65	7.00	6.07	1.09	0.62	0.16
pons, adult, pool1	10033-101E6	31.41	10.41	4.39	3.79	0.34	0.34
postcentral gyrus, adult, pool1	10032-101E5	16.74	5.06	2.18	1.66	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	27.19	6.27	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.82	4.81	2.91	0.58	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	17.97	3.99	3.63	0.18	0.00	0.36
prostate, adult, pool1	10022-101D4	39.36	6.35	5.26	0.73	0.09	0.18
putamen, adult, donor10196	10176-103C5	30.92	6.37	2.60	2.83	0.24	0.00
putamen, adult, donor10252	10152-102I8	50.98	7.84	1.96	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	3.28	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	26.34	6.04	1.69	2.42	0.72	0.24
putamen, newborn, donor10223	10365-105F5	14.24	9.75	0.75	2.25	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	34.33	6.40	9.31	1.45	0.29	0.58
rectum, fetal, donor1	10067-101I4	41.73	6.95	4.17	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	20.14	6.78	1.27	0.42	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	42.66	9.94	2.49	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	24.45	4.87	2.58	1.39	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	23.64	5.20	3.90	0.78	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	17.21	3.57	5.29	0.49	0.25	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.68	2.81	6.19	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	21.22	6.06	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	11.65	6.96	1.94	0.65	0.16	0.16
salivary acinar cells, donor2	11772-123I8	20.10	9.50	3.58	1.51	0.14	0.14
salivary acinar cells, donor3	11773-123I9	22.51	10.59	2.65	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	26.88	5.15	7.44	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	18.72	6.41	2.61	0.84	0.51	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	20.22	5.17	2.59	0.35	0.82	0.35
seminal vesicle, adult	10201-103F3	57.67	16.40	4.76	2.12	2.12	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.95	15.79	3.16	3.89	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	9.06	2.01	1.01	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	15.05	3.01	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.63	9.27	2.01	1.07	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	19.45	8.51	3.43	1.44	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	24.90	8.13	3.87	0.90	0.13	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	27.66	2.13	0.71	0.00	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	42.34	6.00	5.16	0.36	0.12	0.96
skeletal muscle, fetal, donor1	10066-101I3	18.09	2.01	3.02	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	37.87	2.52	4.42	1.26	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.67	5.00	4.67	1.00	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	22.06	4.73	5.04	0.32	1.26	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	15.61	4.05	0.77	0.96	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	10.05	3.30	1.15	1.65	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	43.59	9.97	2.90	0.97	1.13	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	20.70	2.83	6.76	0.65	0.44	0.22
small intestine, adult, pool1	10024-101D6	48.49	16.84	8.24	1.79	0.36	0.36
small intestine, fetal, donor1	10064-101I1	23.59	5.65	5.41	0.25	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	24.11	5.13	3.08	1.03	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	23.78	4.65	1.55	0.52	0.52	0.78
somatostatinoma cell line:QGP-1	10781-110G7	27.07	5.36	3.22	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	19.73	5.28	2.06	2.52	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	24.84	6.70	3.94	2.76	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	11.76	4.84	2.77	0.69	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	34.76	4.27	1.83	2.44	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	33.98	11.02	3.67	2.30	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.77	4.03	3.58	0.15	0.30	0.15
spleen, adult, pool1	10025-101D7	30.73	6.83	4.19	0.11	0.33	0.11
spleen, fetal, pool1	10044-101F8	26.30	4.77	1.75	0.16	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.50	13.66	5.59	1.04	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.19	7.41	4.75	0.57	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	15.38	5.24	3.15	1.40	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.03	19.16	10.95	0.39	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.57	9.79	6.87	1.24	0.23	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	1.27	0.85	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	22.85	3.38	2.96	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	40.58	4.27	4.27	2.14	1.07	0.00
submaxillary gland, adult	10202-103F4	55.83	11.39	9.11	0.57	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.66	10.80	3.74	2.28	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	19.14	5.69	1.55	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.02	8.48	0.00	1.41	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.07	6.65	2.75	0.23	0.92	0.23
temporal lobe, adult, pool1	10031-101E4	15.51	3.31	1.44	1.36	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.76	4.27	3.56	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	33.40	2.64	3.52	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	21.30	3.84	3.84	0.00	0.35	0.00
tenocyte, donor2	11765-123I1	16.40	4.96	3.43	0.38	1.53	0.00
tenocyte, donor3	11768-123I4	17.05	5.19	1.85	1.11	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	8.33	0.68	1.70	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	14.95	4.93	3.39	1.08	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	11.93	3.87	1.55	0.46	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	19.42	4.70	3.94	0.38	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.20	4.54	1.89	2.27	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	35.01	4.14	4.36	0.87	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	26.38	10.42	5.54	1.30	0.98	0.00
testis, adult, pool1	10026-101D8	46.49	28.45	5.26	3.44	0.32	0.54
testis, adult, pool2	10096-102C6	46.91	23.91	1.35	5.41	2.26	0.00
thalamus - adult, donor10196	10168-103B6	35.33	13.25	3.31	4.42	0.00	0.00
thalamus, adult, donor10252	10154-103A1	38.13	12.35	4.22	2.34	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	38.49	12.32	0.00	3.08	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	15.15	5.93	3.95	1.81	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	19.56	6.90	0.58	1.15	0.00	0.00
throat, adult	10209-103G2	35.70	7.49	2.50	1.25	0.00	0.25
throat, fetal, donor1	10061-101H7	37.78	5.79	3.35	0.91	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	23.65	7.95	2.78	1.39	0.40	0.00
thymus, adult, pool1	10027-101D9	42.35	10.44	3.68	1.09	0.20	0.10
thymus, fetal, pool1	10043-101F7	49.25	11.64	4.99	1.04	0.21	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	12.63	7.31	1.46	0.13	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	17.32	5.31	3.63	1.12	0.42	0.28
thyroid, adult, pool1	10028-101E1	45.82	8.49	4.57	1.49	0.28	0.00
thyroid, fetal, donor1	10060-101H6	35.33	6.59	6.59	2.37	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	21.56	9.24	0.00	0.00	0.00
tongue, adult	10203-103F5	19.30	4.19	1.40	1.16	0.70	0.47
tongue, fetal, donor1	10059-101H5	25.22	3.94	3.15	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	27.55	7.41	3.01	0.50	0.10	0.00
trachea, adult, pool1	10029-101E2	46.22	13.25	5.48	1.39	0.25	0.08
trachea, fetal, donor1	10058-101H4	44.62	7.31	2.69	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.36	6.73	4.61	1.06	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	14.49	2.94	3.75	0.51	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	34.63	5.80	4.07	0.31	1.72	0.16
tridermal teratoma cell line:HGRT	10694-109G1	15.22	7.61	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.45	2.45	1.61	0.17	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	16.69	6.26	6.26	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	37.20	4.61	3.41	1.19	0.00	0.00
uterus, fetal, donor1	10055-101H1	44.54	6.14	3.07	1.02	0.51	0.00
vagina, adult	10204-103F6	38.77	2.58	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	30.69	5.48	2.85	1.32	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.82	3.74	2.14	0.53	0.00	0.00